San Francisco Sentry Investment Group’s Intersect ENT, Inc XENT Stock Holding History

San Francisco Sentry Investment Group’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,500	Closed	-$37K	–	1020
2019 Q4	$37K	Hold	1,500	–	–	0.02%	411
2019 Q3	$26K	Hold	1,500	–	–	0.01%	456
2019 Q2	$34K	Hold	1,500	–	–	0.02%	421
2019 Q1	$48K	Hold	1,500	–	–	0.02%	397
2018 Q4	$42K	Sell	1,500 -1,500	-50%	-$43.9K	0.02%	392
2018 Q3	$86K	Sell	3,000 -400	-12%	-$12K	0.03%	336
2018 Q2	$127K	Hold	3,400	–	–	0.05%	272
2018 Q1	$134K	Hold	3,400	–	–	0.04%	324
2017 Q4	$110K	Hold	3,400	–	–	0.03%	345
2017 Q3	$106K	Hold	3,400	–	–	0.04%	330
2017 Q2	$95K	Buy	+3,400	New	+$77K	0.03%	299

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

San Francisco Sentry Investment Group's XENT Position: Q1 2020 in Review

San Francisco Sentry Investment Group sold out of Intersect ENT, Inc (XENT) in Q1 2020, closing a stake of 1,500 shares — an estimated $37K sold.

San Francisco Sentry Investment Group first reported a position in XENT in Q2 2017 and held it in 11 quarters. The position peaked at $134K in Q1 2018. 121 funds tracked by Wall St. Rank hold XENT as of Q1 2020.

San Francisco Sentry Investment Group reported no remaining Intersect ENT, Inc position as of Q1 2020 after selling out during the quarter.
San Francisco Sentry Investment Group sold 1,500 Intersect ENT, Inc shares in Q1 2020, an estimated $37K.
San Francisco Sentry Investment Group first reported a position in Intersect ENT, Inc in Q2 2017 and held it in 11 quarters.
San Francisco Sentry Investment Group's Intersect ENT, Inc position peaked at $134K in Q1 2018.
121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2020, filed 9 Apr 2020.